Growth Metrics

Integra Lifesciences Holdings (IART) Cash from Operations (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -17.04%
Dec 31, 2025 -71.11%
Sep 30, 2025 358.64%
Jun 30, 2025 179.23%
Mar 31, 2025 -122.19%
Dec 31, 2024 125.66%
Sep 30, 2024 -44.35%
Jun 30, 2024 156.42%
Mar 31, 2024 -73.18%
Dec 31, 2023 119.46%
Sep 30, 2023 -5.34%
Jun 30, 2023 8.12%
Mar 31, 2023 -69.35%
Dec 31, 2022 24.92%
Sep 30, 2022 2.76%
Jun 30, 2022 49.91%
Mar 31, 2022 -35.99%
Dec 31, 2021 -16.31%
Sep 30, 2021 -9.32%
Jun 30, 2021 32.15%
Mar 31, 2021 -13.93%
Dec 31, 2020 15.25%
Sep 30, 2020 110.28%
Jun 30, 2020 59.11%
Mar 31, 2020 -76.66%
Dec 31, 2019 38.83%
Sep 30, 2019 32.39%
Jun 30, 2019 64.58%
Mar 31, 2019 -30.93%
Dec 31, 2018 -46.14%
Sep 30, 2018 118.85%
Jun 30, 2018 -12.80%
Mar 31, 2018 259.61%
Dec 31, 2017 -74.47%
Sep 30, 2017 56.70%
Jun 30, 2017 -0.04%
Mar 31, 2017 342.36%
Dec 31, 2016 -86.04%
Sep 30, 2016 22.82%
Jun 30, 2016 52.13%
Mar 31, 2016 -2.38%
Dec 31, 2015 30.74%
Sep 30, 2015 -51.21%
Jun 30, 2015 27.12%
Mar 31, 2015 645.91%
Dec 31, 2014 -86.36%
Sep 30, 2014 89.75%
Jun 30, 2014 45.52%
Mar 31, 2014 -1.87%
Dec 31, 2013 -62.77%
Sep 30, 2013 955.79%
Jun 30, 2013 -62.81%
Mar 31, 2013 330.56%
Dec 31, 2012 -112.19%
Sep 30, 2012 1,126.23%
Jun 30, 2012 -92.96%
Mar 31, 2012 -6.85%
Dec 31, 2011 45.81%
Sep 30, 2011 -3.21%
Jun 30, 2011 15.66%
Mar 31, 2011 -25.24%
Dec 31, 2010 -4.10%
Sep 30, 2010 53.15%
Jun 30, 2010 -31.20%
Mar 31, 2010 -40.19%
Dec 31, 2009 65.85%